![Adi Zuloff-Shani](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Adi Zuloff-Shani
Algemeen Directeur bij CLEARMIND MEDICINE INC.
Vermogen: 1 884 $ op 31-05-2024
Profiel
Adi Zuloff-Shani is currently the Chief Executive Officer at Clearmind Medicine, Inc., Chairman at Orsus Therapeutics Plc, Director at MitoCareX Bio Ltd., and Chief Technology Officer at SciSparc Ltd.
Previously, Adi held the position of Vice President-Development at Macrocure Ltd.
Adi's education includes undergraduate and doctorate degrees from Bar-Ilan University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
CLEARMIND MEDICINE INC.
0.05% | 31-10-2023 | 1 667 ( 0.05% ) | 1 884 $ | 31-05-2024 |
SCISPARC LTD.
-.--% | 28-03-2024 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Adi Zuloff-Shani
Bedrijven | Functie | Begin |
---|---|---|
SCISPARC LTD. | Hoofd Techniek/Wetenschap/O&O | 08-02-2016 |
CLEARMIND MEDICINE INC. | Algemeen Directeur | 14-07-2021 |
Orsus Therapeutics Plc | Voorzitter | 01-11-2021 |
Eerdere bekende functies van Adi Zuloff-Shani
Bedrijven | Functie | Einde |
---|---|---|
MACROCURE LTD | Corporate Officer/Principal | 01-01-2016 |
Opleiding van Adi Zuloff-Shani
Bar-Ilan University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
SCISPARC LTD. | Health Technology |
CLEARMIND MEDICINE INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Macrocure Ltd.
![]() Macrocure Ltd. Medical SpecialtiesHealth Technology Macrocure Ltd. is a clinical-stage biotechnology company, which engages in the development and commercialization of advanced cell therapy products. Its product, CureXcell, is an advanced wound care therapy that treat such wounds by injecting living human white blood cells that have been activate to facilitate the healing process. The company was founded by David Ben-Ami on January 14, 2008 and is headquartered in Petach Tikva, Israel. | Health Technology |
Orsus Therapeutics Plc |